Login to Your Account



SEEK's $38M to Back Spin-off; Keeps Vaccine, Antiviral Focus


Wednesday, March 27, 2013

SEEK Ltd. has raised £25 million (US$37.9 million) to fund its spin-off, infirst Healthcare Ltd., toward an independent existence as a specialist in patent-protected over-the-counter (OTC) treatments.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription